[Corrections] Correction to Lancet Oncol 2025; 26: 1227–39

Ma D, Price K, Moore E, et al. De-escalated adjuvant radiotherapy versus standard adjuvant treatment for human papillomavirus-associated oropharyngeal squamous cell carcinoma (MC1675): a phase 3, open-label, randomised controlled trial. Lancet Oncol 2025; 26: 1227–39—In table 1 of this Article, the number of participants in each AJCC 8th edition N stage and AJCC 7th edition N stage at baseline have been corrected. This correction has been made as of Dec 22, 2025.